PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
PET-CT FDG: 700 USD
PET-CT Ga68 PSMA: 1700 USD
Full-Body MRI (3 Tesla): 900 USD
Stereotactic Radiosurgery (SRS): 4500 USD
Radiotherapy Treatment (Starts from): 4000 USD
Radioactive Iodine Therapy (Starts from): 3500 USD
Check-up (Starts from): 900 USD
Lu-177 PSMA Therapy: 9000 USD
Ac-225 PSMA Therapy (Starts from): 16000 USD
Brain Surgery (Starts from): 15000 USD
Breast Cancer Surgery (Starts from): 8000 USD
MIBG Scan (Starts from): 2500 USD
Medical imaging has transformed healthcare, allowing earlier and more accurate diagnosis, guiding precise treatment plans, and significantly improving patient outcomes. One advanced imaging technique that has revolutionized cancer diagnosis and management is the FDG PET-CT scan. In this comprehensive guide, we’ll dive into what FDG PET-CT scans are, their indications, advantages, and everything you should know about this powerful diagnostic tool.
FDG PET-CT (Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography) combines two advanced imaging technologies: PET (Positron Emission Tomography) and CT (Computed Tomography). PET uses a radioactive tracer (FDG, a glucose analog) injected into the patient’s bloodstream, highlighting areas of metabolic activity—usually cancer cells—because they consume glucose more rapidly than normal cells. The CT component captures detailed anatomical images, providing precise localization of metabolic abnormalities. By merging these two modalities into one scan, clinicians can obtain both metabolic and anatomical information in a single examination, enhancing diagnostic accuracy.
An FDG PET-CT scan is often recommended for:
By combining metabolic and anatomical imaging, FDG PET-CT provides more precise localization of abnormalities compared to using PET or CT alone. This results in improved diagnosis, staging, and therapeutic planning.
PET-CT scans can detect cellular-level changes in metabolic activity, identifying abnormalities earlier than traditional imaging methods, which typically detect anatomical changes only after they have become more advanced.
PET-CT aids oncologists in developing personalized treatment approaches tailored to the individual patient’s condition by accurately determining disease extent and response to therapy.
By providing comprehensive information in one examination, patients avoid multiple scans and procedures, reducing stress, radiation exposure, and overall healthcare costs.
FDG PET-CT accurately pinpoints metabolically active tumors, allowing physicians to precisely target biopsies or surgical interventions, leading to better clinical outcomes.
Prior to an FDG PET-CT scan, patients are generally instructed to fast for approximately 6 hours to ensure optimal imaging results. Patients should inform their doctor of medications and conditions such as diabetes or pregnancy. After intravenous injection of the FDG tracer, patients typically wait 45 to 60 minutes to allow proper distribution. The scan itself lasts around 20–30 minutes, during which patients must remain still to ensure clear images. The procedure is painless, with minimal discomfort.
FDG PET-CT scans are safe and widely used in clinical practice. The amount of radiation exposure is carefully controlled and comparable to other diagnostic imaging tests. Allergic reactions to FDG tracer are extremely rare, and side effects are uncommon. However, always discuss your specific medical condition and any potential risks with your healthcare provider prior to the procedure.
Once completed, the images are analyzed by a specialist nuclear medicine physician or radiologist, and results are typically available within a few days. These results will guide your physician in determining the next steps, whether that includes further diagnostics, initiating treatment, or continued monitoring.
FDG PET-CT scans provide unparalleled accuracy, safety, and comprehensive diagnostic information that significantly enhances cancer diagnosis, staging, treatment monitoring, and patient care. Understanding the benefits, indications, and procedures involved with FDG PET-CT will help you make informed decisions alongside your healthcare provider, improving your treatment experience and outcomes.
WhatsApp us